Assessing a Novel Virtual Environment That Assists With Activities of Daily Living

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

38 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-06-09

Study Completion Date

2023-10-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This Phase 1 study looks at how a new videogame-based program can help residents and care partners prepare for ADLs in a fun way with minimal risk, potentially reducing escalating problems associated with ADL completions.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Vanquishing Apathy Through E-inclusion Using Realistic Virtual Environment Project

NCT01798199

Alzheimer's Disease

COMPLETED NA

Virtual Reality Intervention for the Reduction of Behavioral and Psychological Symptoms of Dementia

NCT04769024

Dementia Alzheimer's Disease Neurocognitive Disorders

COMPLETED NA

A Novel VIRTUAL Reality Intervention for CAREgivers of People With Dementia (VirtualCare)

NCT05780476

Caregiver Burden

UNKNOWN NA

Toolkit for Experiential Well-beiNg in Dementia (TEND)

NCT06257563

Dementia Alzheimer Disease

WITHDRAWN NA

Evaluation of the Effectiveness of Virtual Reality Headsets With Hypnotic Scenarios for Hygiene Care in Patients With Alzheimer's Disease or Related Disorders With Behavioral Disturbances

NCT07264439

Effectiveness Virtual Reality Hypnotic Scenarios +3 more

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Central themes in person-centered care are dignity/respect/choice for the care recipient.

This Phase l clinical study is a minimal risk study that focuses on how the new technology can support and amplify these principles, while assisting care staff.

The investigators will use a novel digital health device developed with user-centered design principles, mirroring a range of evidence-based non-pharmacological interventions for people living with Alzheimer's disease and its related dementias (AD/ADRD). This is a purpose-built virtual world depicting activities of daily living (ADLs). It contains interactive engagement stimuli, including customized digital artifacts that hold meaning to the person.

The investigators hypothesize that undertaking ADL-related virtual activities will support completions of actual ADLs, thereby increasing effectiveness and improving care outcomes.

Aim 1: Feasibility Successful outcomes are \>55% participation rate and a statistically significant difference between assessments of participation and non-participation, indicating tolerability and acceptability of routine interventions.

Aim 2: Effectiveness

Successful outcomes are:

* a reduction in ADL-related care challenges compared to baseline
* reduced time spent on the evening ADLs compared to baseline
* a reduction in negative response behaviors associated with the ADL
* greater interest in the ADL
* a positive shift in care staff attitudes

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dementia Alzheimer Disease Neurodegenerative Diseases

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

A Virtual Game Environment as a Behavioral Intervention for Alzheimer Disease

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Persons residing in long-term care homes

Subjects' ADLs are studied with intervention compared to baseline (without intervention).

Group Type EXPERIMENTAL

A novel digital health device

Intervention Type DEVICE

A videogame-generated virtual world designed for the AD/ADRD care dyad.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

A novel digital health device

A videogame-generated virtual world designed for the AD/ADRD care dyad.

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

DevaWorld

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

The subject will have a diagnosis of AD/ADRD, or symptoms of an undiagnosed AD/ADRD as observed by professional care staff and confirmed by the head of clinical care. The investigators will neither include nor exclude participation based on cognitive test scores. The subject will have had challenge(s) completing one or more ADLs in the previous month, as discussed at staff meetings, referenced in care plans, or observed/experienced by direct care staff.

Other specifications:

* Understand English or Russian.
* Can sit comfortably for at least 15 minutes in a chair/wheelchair at a table or propped up in bed or princess chair with a tray table
* Are not known to be in pain
* Have good vision, or good corrected vision (i.e., glasses)
* Have good hearing, or good corrected hearing (i.e., aids)
* May sometimes have anxiety or agitation when undertaking ADLs.

Exclusion Criteria

Ineligible subjects are those with significant non-AD/ADRD neurological, psychiatric, or physical impairment or those who are totally dependent upon others for ADLs.

Maximum Eligible Age

110 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No